| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.944 | 0.004 | 0.944 | Cyclophilin D inhibitor | 0.397 0.093 CHEMBL187265 0.282 0.179 CHEMBL389166 | ||
| 0.899 | 0.003 | 0.899 | Hypoglycemic | 0.542 0.012 CHEMBL187265 0.439 0.022 CHEMBL389166 | ||
| 0.891 | 0.003 | 0.891 | Caspase 9 stimulant | 0.891 0.003 CHEMBL187265 0.874 0.004 CHEMBL389166 | ||
| 0.887 | 0.004 | 0.887 | Antioxidant | 0.876 0.004 CHEMBL187265 0.715 0.005 CHEMBL389166 | ||
| 0.876 | 0.009 | 0.876 | Alpha-glucosidase inhibitor | 0.697 0.034 CHEMBL187265 0.612 0.051 CHEMBL389166 | ||
| 0.822 | 0.003 | 0.822 | Monophenol monooxygenase inhibitor | 0.657 0.004 CHEMBL187265 0.519 0.007 CHEMBL389166 | ||
| 0.815 | 0.002 | 0.815 | Melanin inhibitor | 0.616 0.004 CHEMBL187265 0.53 0.006 CHEMBL389166 | ||
| 0.826 | 0.014 | 0.846 | Apoptosis agonist | 0.846 0.011 CHEMBL187265 0.752 0.023 CHEMBL389166 | CHEMBL187265 | |
| 0.81 | 0.004 | 0.866 | Free radical scavenger | 0.866 0.003 CHEMBL187265 0.723 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.806 | 0.004 | 0.806 | Vasodilator, coronary | 0.482 0.018 CHEMBL187265 0.466 0.021 CHEMBL389166 | ||
| 0.8 | 0.013 | 0.8 | Transcription factor NF kappa B inhibitor | 0.679 0.023 CHEMBL187265 0.59 0.032 CHEMBL389166 | ||
| 0.753 | 0.003 | 0.753 | Amylase inhibitor | 0.58 0.004 CHEMBL187265 0.45 0.007 CHEMBL389166 | ||
| 0.743 | 0.004 | 0.842 | Histamine release inhibitor | 0.842 0.003 CHEMBL187265 0.822 0.003 CHEMBL389166 | CHEMBL187265 | |
| 0.751 | 0.022 | 0.751 | Antiinflammatory | 0.689 0.033 CHEMBL187265 0.551 0.068 CHEMBL389166 | ||
| 0.706 | 0.005 | 0.706 | Angiogenesis stimulant | 0.375 0.026 CHEMBL187265 0.315 0.044 CHEMBL389166 | ||
| 0.677 | 0.005 | 0.677 | DNA damaging | 0.5 0.014 CHEMBL187265 0.441 0.02 CHEMBL389166 | ||
| 0.661 | 0.005 | 0.661 | Apoptosis antagonist | 0.581 0.012 CHEMBL187265 0.455 0.027 CHEMBL389166 | ||
| 0.659 | 0.005 | 0.81 | Amyloid beta aggregation inhibitor | 0.81 0.004 CHEMBL187265 0.65 0.006 CHEMBL389166 | CHEMBL187265 | |
| 0.657 | 0.004 | 0.657 | Hepatoprotectant | 0.486 0.008 CHEMBL187265 0.372 0.016 CHEMBL389166 | ||
| 0.661 | 0.012 | 0.661 | Antibacterial | 0.508 0.038 CHEMBL187265 0.46 0.053 CHEMBL389166 | ||
| 0.65 | 0.005 | 0.65 | Antiamyloidogenic | 0.547 0.012 CHEMBL187265 0.443 0.022 CHEMBL389166 | ||
| 0.649 | 0.004 | 0.665 | NOS3 expression enhancer | 0.665 0.004 CHEMBL187265 0.523 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.649 | 0.008 | 0.649 | Nitric oxide antagonist | 0.58 0.011 CHEMBL187265 0.44 0.021 CHEMBL389166 | ||
| 0.642 | 0.002 | 0.642 | AMP-activated protein kinase stimulant | 0.198 0.011 CHEMBL187265 0.171 0.017 CHEMBL389166 | ||
| 0.608 | 0.007 | 0.608 | Hypoxia-inducible factor 1 alpha inhibitor | 0.589 0.008 CHEMBL187265 0.55 0.01 CHEMBL389166 | ||
| 0.603 | 0.004 | 0.603 | Aldehyde dehydrogenase inhibitor | 0.58 0.004 CHEMBL187265 0.56 0.004 CHEMBL389166 | ||
| 0.601 | 0.003 | 0.605 | Xanthine oxidase inhibitor | 0.605 0.003 CHEMBL187265 0.453 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.578 | 0.006 | 0.578 | RNA-directed DNA polymerase inhibitor | 0.503 0.011 CHEMBL187265 0.419 0.016 CHEMBL389166 | ||
| 0.556 | 0.003 | 0.605 | Carbonic anhydrase III inhibitor | 0.605 0.003 CHEMBL187265 0.525 0.003 CHEMBL389166 | CHEMBL187265 | |
| 0.526 | 0.005 | 0.526 | Insulin secretagoues | 0.179 0.049 CHEMBL187265 0.152 0.072 CHEMBL389166 | ||
| 0.518 | 0.005 | 0.518 | Interferon gamma antagonist | 0.3 0.02 CHEMBL187265 0.287 0.022 CHEMBL389166 | ||
| 0.506 | 0.005 | 0.506 | Platelet adhesion inhibitor | 0.39 0.012 CHEMBL187265 0.331 0.024 CHEMBL389166 | ||
| 0.515 | 0.018 | 0.738 | Caspase 3 stimulant | 0.738 0.005 CHEMBL187265 0.635 0.008 CHEMBL389166 | CHEMBL187265 | |
| 0.497 | 0.007 | 0.635 | Topoisomerase II inhibitor | 0.635 0.004 CHEMBL187265 0.595 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.494 | 0.005 | 0.494 | Alkylator | 0.245 0.017 CHEMBL187265 0.211 0.023 CHEMBL389166 | ||
| 0.497 | 0.014 | 0.497 | DNA synthesis inhibitor | 0.245 0.07 CHEMBL187265 0.276 0.053 CHEMBL389166 | ||
| 0.484 | 0.003 | 0.484 | UDP-glucose 4-epimerase inhibitor | 0.161 0.025 CHEMBL187265 0.182 0.021 CHEMBL389166 | ||
| 0.474 | 0.003 | 0.474 | Carbonic anhydrase XIII inhibitor | 0.426 0.004 CHEMBL187265 0.337 0.005 CHEMBL389166 | ||
| 0.49 | 0.034 | 0.955 | Aldehyde oxidase inhibitor | 0.955 0.002 CHEMBL187265 0.944 0.003 CHEMBL389166 | CHEMBL187265 | |
| 0.481 | 0.032 | 0.481 | Antithrombotic | 0.31 0.081 CHEMBL187265 0.297 0.09 CHEMBL389166 | ||
| 0.471 | 0.033 | 0.471 | Immunostimulant | 0.283 0.084 CHEMBL187265 0.252 0.095 CHEMBL389166 | ||
| 0.436 | 0.006 | 0.436 | Protein kinase stimulant | 0.37 0.01 CHEMBL187265 0.3 0.017 CHEMBL389166 | ||
| 0.438 | 0.018 | 0.47 | Vasodilator | 0.47 0.014 CHEMBL187265 0.4 0.023 CHEMBL389166 | CHEMBL187265 | |
| 0.424 | 0.008 | 0.528 | Lipid peroxidase inhibitor | 0.528 0.005 CHEMBL187265 0.402 0.009 CHEMBL389166 | CHEMBL187265 | |
| 0.42 | 0.005 | 0.605 | Interleukin 4 antagonist | 0.605 0.004 CHEMBL187265 0.436 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.452 | 0.046 | 0.452 | Immunosuppressant | 0.275 0.131 CHEMBL187265 0.237 0.159 CHEMBL389166 | ||
| 0.409 | 0.005 | 0.856 | Cystathionine beta-synthase inhibitor | 0.856 0.001 CHEMBL187265 0.696 0.002 CHEMBL389166 | CHEMBL187265 | |
| 0.401 | 0.005 | 0.401 | Topoisomerase I inhibitor | 0.384 0.006 CHEMBL187265 0.349 0.008 CHEMBL389166 | ||
| 0.403 | 0.008 | 0.423 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.423 0.006 CHEMBL187265 0.4 0.008 CHEMBL389166 | CHEMBL187265 | |
| 0.383 | 0.012 | 0.383 | DNA methylase inhibitor | 0.313 0.024 CHEMBL187265 0.31 0.025 CHEMBL389166 | ||
| 0.372 | 0.005 | 0.572 | Topoisomerase II alpha inhibitor | 0.572 0.003 CHEMBL187265 0.512 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.369 | 0.005 | 0.369 | Expectorant | 0.202 0.02 CHEMBL187265 0.2 0.02 CHEMBL389166 | ||
| 0.366 | 0.004 | 0.366 | Uric acid excretion stimulant | 0.323 0.005 CHEMBL187265 0.26 0.006 CHEMBL389166 | ||
| 0.366 | 0.006 | 0.595 | NADPH oxidase inhibitor | 0.595 0.004 CHEMBL187265 0.487 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.364 | 0.006 | 0.364 | Antineoplastic antibiotic | 0.209 0.02 CHEMBL187265 0.176 0.025 CHEMBL389166 | ||
| 0.397 | 0.041 | 0.514 | Spasmolytic | 0.514 0.021 CHEMBL187265 0.462 0.029 CHEMBL389166 | CHEMBL187265 | |
| 0.386 | 0.032 | 0.386 | Interleukin 2 agonist | |||
| 0.359 | 0.005 | 0.512 | Carbonic anhydrase VI inhibitor | 0.512 0.003 CHEMBL187265 0.432 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.352 | 0.014 | 0.352 | DNA methyltransferase I inhibitor | 0.327 0.018 CHEMBL187265 0.319 0.02 CHEMBL389166 | ||
| 0.363 | 0.026 | 0.824 | Peroxidase inhibitor | 0.824 0.002 CHEMBL187265 0.761 0.002 CHEMBL389166 | CHEMBL187265 | |
| 0.341 | 0.013 | 0.341 | Alpha-N-acetylglucosaminidase inhibitor | 0.225 0.028 CHEMBL187265 0.225 0.028 CHEMBL389166 | ||
| 0.336 | 0.014 | 0.405 | Protein-tyrosine phosphatase inhibitor | 0.405 0.008 CHEMBL187265 0.332 0.014 CHEMBL389166 | CHEMBL187265 | |
| 0.357 | 0.036 | 0.408 | Tumour necrosis factor alpha release inhibitor | 0.408 0.026 CHEMBL187265 0.296 0.055 CHEMBL389166 | CHEMBL187265 | |
| 0.328 | 0.011 | 0.328 | Insulin sensitizer | 0.252 0.033 CHEMBL187265 0.244 0.038 CHEMBL389166 | ||
| 0.321 | 0.004 | 0.321 | DNA repair enzyme inhibitor | 0.198 0.009 CHEMBL187265 0.196 0.009 CHEMBL389166 | ||
| 0.343 | 0.027 | 0.36 | Cyclic AMP phosphodiesterase inhibitor | 0.36 0.023 CHEMBL187265 0.324 0.033 CHEMBL389166 | CHEMBL187265 | |
| 0.334 | 0.023 | 0.547 | P-glycoprotein inhibitor | 0.547 0.006 CHEMBL187265 0.466 0.01 CHEMBL389166 | CHEMBL187265 | |
| 0.362 | 0.06 | 0.362 | Cholesterol antagonist | 0.216 0.151 CHEMBL187265 0.276 0.107 CHEMBL389166 | ||
| 0.357 | 0.057 | 0.357 | Immunomodulator | |||
| 0.308 | 0.011 | 0.308 | DNA polymerase I inhibitor | 0.223 0.022 CHEMBL187265 0.132 0.06 CHEMBL389166 | ||
| 0.304 | 0.01 | 0.433 | Nitric-oxide synthase stimulant | 0.433 0.003 CHEMBL187265 0.352 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.299 | 0.005 | 0.299 | Selectin antagonist | |||
| 0.292 | 0.007 | 0.515 | Histidine decarboxylase inhibitor | 0.515 0.003 CHEMBL187265 0.403 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.295 | 0.011 | 0.35 | Protein-tyrosine phosphatase 1B inhibitor | 0.35 0.008 CHEMBL187265 0.273 0.013 CHEMBL389166 | CHEMBL187265 | |
| 0.289 | 0.008 | 0.304 | Mediator release inhibitor | 0.304 0.007 CHEMBL187265 0.247 0.01 CHEMBL389166 | CHEMBL187265 | |
| 0.293 | 0.013 | 0.409 | Alkaline phosphatase inhibitor | 0.409 0.005 CHEMBL187265 0.33 0.009 CHEMBL389166 | CHEMBL187265 | |
| 0.273 | 0.005 | 0.383 | Aldose reductase inhibitor | 0.383 0.004 CHEMBL187265 0.282 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.275 | 0.007 | 0.44 | Beta glucuronidase inhibitor | 0.44 0.004 CHEMBL187265 0.339 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.294 | 0.027 | 0.294 | Peptidyltransferase inhibitor | 0.219 0.078 CHEMBL187265 0.208 0.089 CHEMBL389166 | ||
| 0.268 | 0.005 | 0.501 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.501 0.002 CHEMBL187265 0.478 0.003 CHEMBL389166 | CHEMBL187265 | |
| 0.277 | 0.016 | 0.277 | Adenylate cyclase inhibitor | 0.155 0.041 CHEMBL187265 0.178 0.031 CHEMBL389166 | ||
| 0.265 | 0.006 | 0.36 | Alcohol dehydrogenase inhibitor | 0.36 0.004 CHEMBL187265 0.301 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.254 | 0.005 | 0.627 | Creatine kinase inhibitor | 0.627 0.001 CHEMBL187265 0.503 0.002 CHEMBL389166 | CHEMBL187265 | |
| 0.249 | 0.008 | 0.249 | NADH dehydrogenase inhibitor | 0.129 0.024 CHEMBL187265 0.138 0.021 CHEMBL389166 | ||
| 0.25 | 0.016 | 0.25 | DNA intercalator | 0.239 0.018 CHEMBL187265 0.235 0.018 CHEMBL389166 | ||
| 0.242 | 0.01 | 0.242 | Cyclooxygenase 3 inhibitor | 0.223 0.013 CHEMBL187265 0.21 0.016 CHEMBL389166 | ||
| 0.241 | 0.01 | 0.411 | Telomerase inhibitor | 0.411 0.004 CHEMBL187265 0.329 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.254 | 0.036 | 0.313 | Neurotrophic factor enhancer | 0.3 0.018 CHEMBL187265 0.313 0.015 CHEMBL389166 | CHEMBL389166 | |
| 0.22 | 0.007 | 0.281 | Papain-like protease (SARS coronavirus) inhibitor | 0.281 0.004 CHEMBL187265 0.257 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.274 | 0.063 | 0.274 | Interleukin agonist | 0.222 0.101 CHEMBL187265 0.208 0.113 CHEMBL389166 | ||
| 0.226 | 0.019 | 0.23 | Mannose-6-phosphate isomerase inhibitor | 0.23 0.017 CHEMBL187265 0.215 0.023 CHEMBL389166 | CHEMBL187265 | |
| 0.223 | 0.02 | 0.509 | Chelator | 0.509 0.005 CHEMBL187265 0.357 0.008 CHEMBL389166 | CHEMBL187265 | |
| 0.219 | 0.023 | 0.272 | Cholesterol synthesis inhibitor | 0.272 0.015 CHEMBL187265 0.242 0.019 CHEMBL389166 | CHEMBL187265 | |
| 0.208 | 0.017 | 0.456 | Carbonic anhydrase XV inhibitor | 0.456 0.004 CHEMBL187265 0.396 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.202 | 0.013 | 0.202 | Mucolytic | 0.188 0.016 CHEMBL187265 0.194 0.015 CHEMBL389166 | ||
| 0.199 | 0.011 | 0.199 | Phosphofructokinase-1 inhibitor | 0.097 0.033 CHEMBL187265 0.102 0.031 CHEMBL389166 | ||
| 0.197 | 0.01 | 0.413 | HIV-1 integrase (3'-Processing) inhibitor | 0.413 0.004 CHEMBL187265 0.267 0.006 CHEMBL389166 | CHEMBL187265 | |
| 0.198 | 0.017 | 0.198 | Beta amyloid protein antagonist | 0.154 0.038 CHEMBL187265 0.139 0.049 CHEMBL389166 | ||
| 0.178 | 0.002 | 0.178 | Sodium/glucose cotransporter inhibitor | 0.024 0.022 CHEMBL187265 0.027 0.016 CHEMBL389166 | ||
| 0.185 | 0.01 | 0.358 | HIV-1 integrase (Strand Transfer) inhibitor | 0.358 0.004 CHEMBL187265 0.237 0.007 CHEMBL389166 | CHEMBL187265 | |
| 0.202 | 0.029 | 0.202 | Cell wall synthesis inhibitor | 0.192 0.033 CHEMBL187265 0.172 0.045 CHEMBL389166 | ||
| 0.177 | 0.005 | 0.257 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.257 0.003 CHEMBL187265 0.224 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.209 | 0.038 | 0.246 | Phospholipase C inhibitor | 0.232 0.029 CHEMBL187265 0.246 0.026 CHEMBL389166 | CHEMBL389166 | |
| 0.178 | 0.013 | 0.271 | Heat shock protein 70 antagonist | 0.271 0.004 CHEMBL187265 0.232 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.176 | 0.011 | 0.176 | Thioredoxin inhibitor | 0.155 0.015 CHEMBL187265 0.137 0.021 CHEMBL389166 | ||
| 0.173 | 0.015 | 0.173 | Triose-phosphate isomerase inhibitor | 0.115 0.035 CHEMBL187265 0.136 0.025 CHEMBL389166 | ||
| 0.174 | 0.017 | 0.325 | Multidrug resistance-associated protein 1 inhibitor | 0.325 0.004 CHEMBL187265 0.279 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.177 | 0.028 | 0.188 | Adenylate cyclase stimulant | 0.185 0.022 CHEMBL187265 0.188 0.02 CHEMBL389166 | CHEMBL389166 | |
| 0.201 | 0.054 | 0.434 | Dual specificity phosphatase inhibitor | 0.434 0.011 CHEMBL187265 0.384 0.016 CHEMBL389166 | CHEMBL187265 | |
| 0.191 | 0.045 | 0.206 | ATPase inhibitor | 0.205 0.033 CHEMBL187265 0.206 0.032 CHEMBL389166 | CHEMBL389166 | |
| 0.238 | 0.093 | 0.406 | 5 Hydroxytryptamine uptake stimulant | 0.406 0.013 CHEMBL187265 0.369 0.021 CHEMBL389166 | CHEMBL187265 | |
| 0.239 | 0.094 | 0.542 | 5 Hydroxytryptamine release stimulant | 0.324 0.063 CHEMBL187265 0.542 0.021 CHEMBL389166 | CHEMBL389166 | |
| 0.145 | 0.001 | 0.145 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.02 CHEMBL187265 0.029 0.014 CHEMBL389166 | ||
| 0.159 | 0.02 | 0.534 | Estrogen antagonist | 0.534 0.004 CHEMBL187265 0.467 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.224 | 0.085 | 0.224 | Platelet antagonist | |||
| 0.194 | 0.055 | 0.194 | Thrombolytic | 0.162 0.073 CHEMBL187265 0.134 0.095 CHEMBL389166 | ||
| 0.161 | 0.025 | 0.228 | Photosensitizer | 0.228 0.008 CHEMBL187265 0.217 0.01 CHEMBL389166 | CHEMBL187265 | |
| 0.219 | 0.083 | 0.219 | Hypolipemic | |||
| 0.152 | 0.02 | 0.152 | Toll-Like receptor 4 antagonist | 0.117 0.047 CHEMBL187265 0.106 0.06 CHEMBL389166 | ||
| 0.173 | 0.043 | 0.276 | CF transmembrane conductance regulator agonist | 0.276 0.005 CHEMBL187265 0.251 0.006 CHEMBL389166 | CHEMBL187265 | |
| 0.148 | 0.019 | 0.148 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.265 | 0.143 | 0.265 | Antiobesity | |||
| 0.185 | 0.07 | 0.397 | Dual specificity phosphatase 3 inhibitor | 0.397 0.014 CHEMBL187265 0.352 0.02 CHEMBL389166 | CHEMBL187265 | |
| 0.127 | 0.014 | 0.127 | Thioredoxin reductase inhibitor | 0.115 0.019 CHEMBL187265 0.127 0.014 CHEMBL389166 | ||
| 0.118 | 0.007 | 0.239 | Fatty acid synthase inhibitor | 0.239 0.003 CHEMBL187265 0.169 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.123 | 0.015 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.105 0.028 CHEMBL187265 0.097 0.034 CHEMBL389166 | ||
| 0.241 | 0.134 | 0.258 | Vasodilator, peripheral | 0.255 0.123 CHEMBL187265 0.258 0.121 CHEMBL389166 | CHEMBL389166 | |
| 0.15 | 0.043 | 0.169 | Ca2+-transporting ATPase inhibitor | 0.164 0.018 CHEMBL187265 0.169 0.014 CHEMBL389166 | CHEMBL389166 | |
| 0.116 | 0.011 | 0.116 | Phosphorylase inhibitor | |||
| 0.166 | 0.061 | 0.199 | Hexokinase inhibitor | 0.199 0.036 CHEMBL187265 0.198 0.036 CHEMBL389166 | CHEMBL187265 | |
| 0.125 | 0.021 | 0.125 | Glutamate dehydrogenase inhibitor | 0.095 0.033 CHEMBL187265 0.101 0.03 CHEMBL389166 | ||
| 0.285 | 0.183 | 0.687 | 5 Hydroxytryptamine release inhibitor | 0.653 0.006 CHEMBL187265 0.687 0.005 CHEMBL389166 | CHEMBL389166 | |
| 0.147 | 0.049 | 0.217 | Antibacterial (Helicobacter pylori) | 0.217 0.018 CHEMBL187265 0.179 0.029 CHEMBL389166 | CHEMBL187265 | |
| 0.125 | 0.027 | 0.547 | Estrogen receptor beta antagonist | 0.547 0.003 CHEMBL187265 0.49 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.115 | 0.019 | 0.115 | Interferon agonist | 0.092 0.037 CHEMBL187265 0.104 0.025 CHEMBL389166 | ||
| 0.108 | 0.013 | 0.15 | Neuraminidase inhibitor | 0.15 0.005 CHEMBL187265 0.104 0.014 CHEMBL389166 | CHEMBL187265 | |
| 0.139 | 0.044 | 0.139 | Microtubule formation inhibitor | 0.115 0.066 CHEMBL187265 0.115 0.066 CHEMBL389166 | ||
| 0.146 | 0.054 | 0.417 | M18 aspartyl aminopeptidase inhibitor | 0.417 0.004 CHEMBL187265 0.33 0.009 CHEMBL389166 | CHEMBL187265 | |
| 0.129 | 0.037 | 0.161 | Electron transport complex I inhibitor | 0.161 0.016 CHEMBL187265 0.148 0.022 CHEMBL389166 | CHEMBL187265 | |
| 0.106 | 0.015 | 0.166 | Neuraminidase (influenza) inhibitor | 0.166 0.006 CHEMBL187265 0.107 0.014 CHEMBL389166 | CHEMBL187265 | |
| 0.122 | 0.031 | 0.347 | Protein kinase C zeta inhibitor | 0.347 0.004 CHEMBL187265 0.338 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.105 | 0.014 | 0.333 | Xanthine dehydrogenase inhibitor | 0.333 0.003 CHEMBL187265 0.232 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.111 | 0.021 | 0.17 | Carbonic anhydrase VA inhibitor | 0.17 0.008 CHEMBL187265 0.147 0.011 CHEMBL389166 | CHEMBL187265 | |
| 0.162 | 0.073 | 0.166 | Interleukin 6 antagonist | 0.166 0.068 CHEMBL187265 0.14 0.106 CHEMBL389166 | CHEMBL187265 | |
| 0.22 | 0.131 | 0.796 | 12-Lipoxygenase inhibitor | 0.796 0.004 CHEMBL187265 0.725 0.006 CHEMBL389166 | CHEMBL187265 | |
| 0.098 | 0.009 | 0.23 | Carbonic anhydrase VII inhibitor | 0.23 0.004 CHEMBL187265 0.144 0.006 CHEMBL389166 | CHEMBL187265 | |
| 0.117 | 0.028 | 0.117 | Phosphodiesterase 6D inhibitor | 0.109 0.037 CHEMBL187265 0.114 0.031 CHEMBL389166 | ||
| 0.093 | 0.005 | 0.093 | Inosine monophosphate dehydrogenase inhibitor | 0.05 0.015 CHEMBL389166 | ||
| 0.115 | 0.027 | 0.256 | Interleukin 5 antagonist | 0.198 0.005 CHEMBL187265 0.256 0.004 CHEMBL389166 | CHEMBL389166 | |
| 0.111 | 0.024 | 0.188 | Carbonic anhydrase V inhibitor | 0.188 0.008 CHEMBL187265 0.16 0.012 CHEMBL389166 | CHEMBL187265 | |
| 0.103 | 0.016 | 0.407 | Estrogen agonist | 0.407 0.004 CHEMBL187265 0.34 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.149 | 0.069 | 0.193 | Hemostatic | 0.193 0.036 CHEMBL187265 0.143 0.077 CHEMBL389166 | CHEMBL187265 | |
| 0.086 | 0.007 | 0.086 | Glucose-6-phosphate isomerase inhibitor | 0.058 0.021 CHEMBL187265 0.058 0.02 CHEMBL389166 | ||
| 0.133 | 0.057 | 0.133 | Cell adhesion inhibitor | |||
| 0.102 | 0.026 | 0.157 | CDC25A inhibitor | 0.157 0.012 CHEMBL187265 0.093 0.032 CHEMBL389166 | CHEMBL187265 | |
| 0.083 | 0.01 | 0.083 | Alpha-mannosidase inhibitor | |||
| 0.155 | 0.083 | 0.22 | Arachidonic acid antagonist | 0.209 0.025 CHEMBL187265 0.22 0.017 CHEMBL389166 | CHEMBL389166 | |
| 0.206 | 0.134 | 0.656 | Lipoxygenase inhibitor | 0.656 0.007 CHEMBL187265 0.593 0.01 CHEMBL389166 | CHEMBL187265 | |
| 0.076 | 0.004 | 0.076 | Protein 30S ribosomal subunit inhibitor | 0.037 0.011 CHEMBL187265 0.033 0.012 CHEMBL389166 | ||
| 0.098 | 0.029 | 0.236 | Histone deacetylase SIRT1 stimulant | 0.236 0.005 CHEMBL187265 0.143 0.01 CHEMBL389166 | CHEMBL187265 | |
| 0.098 | 0.029 | 0.236 | Histone deacetylase stimulant | 0.236 0.005 CHEMBL187265 0.143 0.01 CHEMBL389166 | CHEMBL187265 | |
| 0.117 | 0.049 | 0.371 | DOPA decarboxylase inhibitor | 0.371 0.002 CHEMBL187265 0.321 0.002 CHEMBL389166 | CHEMBL187265 | |
| 0.138 | 0.071 | 0.198 | Neurotrophic factor | 0.198 0.028 CHEMBL187265 0.133 0.076 CHEMBL389166 | CHEMBL187265 | |
| 0.077 | 0.01 | 0.077 | Adenosine deaminase inhibitor | 0.05 0.031 CHEMBL187265 0.041 0.039 CHEMBL389166 | ||
| 0.102 | 0.037 | 0.102 | Transcription factor NF kappa B stimulant | |||
| 0.084 | 0.019 | 0.084 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.054 0.043 CHEMBL187265 0.057 0.038 CHEMBL389166 | ||
| 0.16 | 0.095 | 0.325 | Succinate dehydrogenase inhibitor | 0.325 0.008 CHEMBL187265 0.316 0.009 CHEMBL389166 | CHEMBL187265 | |
| 0.073 | 0.01 | 0.073 | Mannosidase inhibitor | |||
| 0.069 | 0.006 | 0.069 | Antibiotic Aminoglycoside-like | |||
| 0.094 | 0.032 | 0.466 | Estrogen receptor alpha antagonist | 0.466 0.004 CHEMBL187265 0.408 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.093 | 0.031 | 0.136 | Lipase inhibitor | 0.136 0.013 CHEMBL187265 0.103 0.025 CHEMBL389166 | CHEMBL187265 | |
| 0.154 | 0.092 | 0.193 | Neurotensin receptor agonist | 0.181 0.049 CHEMBL187265 0.193 0.038 CHEMBL389166 | CHEMBL389166 | |
| 0.069 | 0.008 | 0.083 | Arginase inhibitor | 0.083 0.005 CHEMBL187265 0.054 0.013 CHEMBL389166 | CHEMBL187265 | |
| 0.11 | 0.05 | 0.176 | Sphingomyelinase inhibitor | 0.159 0.021 CHEMBL187265 0.176 0.015 CHEMBL389166 | CHEMBL389166 | |
| 0.08 | 0.024 | 0.08 | Interferon inducer | 0.064 0.046 CHEMBL187265 0.071 0.033 CHEMBL389166 | ||
| 0.073 | 0.019 | 0.111 | Carbonic anhydrase XIV inhibitor | 0.111 0.008 CHEMBL187265 0.086 0.015 CHEMBL389166 | CHEMBL187265 | |
| 0.111 | 0.057 | 0.635 | MAO A inhibitor | 0.635 0.004 CHEMBL187265 0.581 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.105 | 0.051 | 0.682 | Breast cancer-resistant protein inhibitor | 0.682 0.004 CHEMBL187265 0.601 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.097 | 0.044 | 0.097 | ATPase (Vacuolar H+) inhibitor | |||
| 0.087 | 0.033 | 0.183 | HIV-1 integrase inhibitor | 0.183 0.005 CHEMBL187265 0.136 0.011 CHEMBL389166 | CHEMBL187265 | |
| 0.233 | 0.18 | 0.77 | 15-Lipoxygenase inhibitor | 0.77 0.008 CHEMBL187265 0.698 0.013 CHEMBL389166 | CHEMBL187265 | |
| 0.157 | 0.107 | 0.288 | Non-steroidal antiinflammatory agent | 0.285 0.032 CHEMBL187265 0.288 0.031 CHEMBL389166 | CHEMBL389166 | |
| 0.075 | 0.027 | 0.075 | Nitric oxide donor | 0.063 0.043 CHEMBL187265 | ||
| 0.073 | 0.027 | 0.127 | Protein kinase C eta inhibitor | 0.127 0.011 CHEMBL187265 0.127 0.011 CHEMBL389166 | CHEMBL389166 | |
| 0.059 | 0.013 | 0.063 | Neuraminidase (Influenza A) inhibitor | 0.063 0.01 CHEMBL187265 0.054 0.019 CHEMBL389166 | CHEMBL187265 | |
| 0.104 | 0.061 | 0.483 | 5-Lipoxygenase inhibitor | 0.483 0.004 CHEMBL187265 0.404 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.099 | 0.055 | 0.099 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.094 0.061 CHEMBL389166 | ||
| 0.12 | 0.078 | 0.49 | Acetylcholinesterase inhibitor | 0.49 0.005 CHEMBL187265 0.375 0.008 CHEMBL389166 | CHEMBL187265 | |
| 0.058 | 0.018 | 0.315 | Estrogen receptor beta agonist | 0.315 0.004 CHEMBL187265 0.251 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.069 | 0.032 | 0.119 | Purinergic P2X1 antagonist | 0.084 0.023 CHEMBL187265 0.119 0.012 CHEMBL389166 | CHEMBL389166 | |
| 0.101 | 0.065 | 0.113 | Adenylate kinase inhibitor | 0.109 0.054 CHEMBL187265 0.113 0.05 CHEMBL389166 | CHEMBL389166 | |
| 0.058 | 0.023 | 0.166 | Topoisomerase II beta inhibitor | 0.152 0.005 CHEMBL187265 0.166 0.004 CHEMBL389166 | CHEMBL389166 | |
| 0.116 | 0.082 | 0.226 | Toll-Like receptor 2 antagonist | 0.213 0.018 CHEMBL187265 0.226 0.014 CHEMBL389166 | CHEMBL389166 | |
| 0.065 | 0.031 | 0.191 | Carbonic anhydrase VB inhibitor | 0.191 0.005 CHEMBL187265 0.162 0.008 CHEMBL389166 | CHEMBL187265 | |
| 0.06 | 0.031 | 0.06 | Protein 50S ribosomal subunit inhibitor | |||
| 0.097 | 0.067 | 0.152 | Anabolic | 0.152 0.017 CHEMBL187265 0.151 0.017 CHEMBL389166 | CHEMBL187265 | |
| 0.041 | 0.012 | 0.135 | ATP citrate lysase inhibitor | 0.135 0.003 CHEMBL187265 0.093 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.091 | 0.063 | 0.19 | Potassium channel (Ca-activated) activator | 0.128 0.037 CHEMBL187265 0.19 0.017 CHEMBL389166 | CHEMBL389166 | |
| 0.045 | 0.019 | 0.243 | Estrogen receptor alpha agonist | 0.243 0.004 CHEMBL187265 0.192 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.033 | 0.007 | 0.033 | Dopamine D1 agonist | 0.031 0.008 CHEMBL187265 | ||
| 0.115 | 0.09 | 0.344 | Bone formation stimulant | 0.344 0.013 CHEMBL187265 0.302 0.017 CHEMBL389166 | CHEMBL187265 | |
| 0.033 | 0.008 | 0.033 | Inosine monophosphate dehydrogenase 1 inhibitor | |||
| 0.109 | 0.084 | 0.186 | Transcription factor STAT6 inhibitor | 0.186 0.009 CHEMBL187265 0.185 0.009 CHEMBL389166 | CHEMBL187265 | |
| 0.054 | 0.031 | 0.071 | Glucose-6-phosphate translocase inhibitor | 0.071 0.015 CHEMBL187265 0.051 0.037 CHEMBL389166 | CHEMBL187265 | |
| 0.062 | 0.04 | 0.302 | Aromatase inhibitor | 0.302 0.005 CHEMBL187265 0.259 0.006 CHEMBL389166 | CHEMBL187265 | |
| 0.059 | 0.037 | 0.059 | Lipocortins synthesis agonist | 0.054 0.051 CHEMBL389166 | ||
| 0.06 | 0.039 | 0.06 | Adenosine A1 receptor antagonist | 0.059 0.04 CHEMBL389166 | ||
| 0.031 | 0.011 | 0.031 | Adenosine A1 receptor agonist | |||
| 0.04 | 0.02 | 0.04 | Phosphoglycerate kinase inhibitor | |||
| 0.036 | 0.016 | 0.11 | Estrogen-related receptor beta antagonist | 0.11 0.002 CHEMBL187265 0.086 0.003 CHEMBL389166 | CHEMBL187265 | |
| 0.067 | 0.048 | 0.119 | Potassium channel large-conductance Ca-activated activator | 0.065 0.05 CHEMBL187265 0.119 0.017 CHEMBL389166 | CHEMBL389166 | |
| 0.024 | 0.005 | 0.025 | Antibiotic Anthracycline-like | 0.021 0.009 CHEMBL187265 0.025 0.005 CHEMBL389166 | CHEMBL389166 | |
| 0.109 | 0.091 | 0.268 | Cyclooxygenase 1 inhibitor | 0.268 0.018 CHEMBL187265 0.23 0.025 CHEMBL389166 | CHEMBL187265 | |
| 0.073 | 0.055 | 0.105 | Phosphodiesterase VI inhibitor | 0.1 0.02 CHEMBL187265 0.105 0.017 CHEMBL389166 | CHEMBL389166 | |
| 0.06 | 0.043 | 0.064 | Carbamoyl phosphate synthetase inhibitor | 0.064 0.039 CHEMBL187265 0.064 0.039 CHEMBL389166 | CHEMBL389166 | |
| 0.072 | 0.055 | 0.072 | Adenosine A3 receptor antagonist | 0.072 0.055 CHEMBL389166 | ||
| 0.042 | 0.027 | 0.042 | Thymidine kinase inhibitor | |||
| 0.021 | 0.007 | 0.021 | Telomerase stimulant | |||
| 0.052 | 0.038 | 0.319 | Alpha tubulin antagonist | 0.319 0.004 CHEMBL187265 0.211 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.047 | 0.033 | 0.047 | Microtubule stabilization | |||
| 0.027 | 0.014 | 0.027 | Vanilloid 2 agonist | 0.025 0.018 CHEMBL187265 0.025 0.018 CHEMBL389166 | ||
| 0.028 | 0.019 | 0.028 | 1,3-Beta-glucan synthase inhibitor | |||
| 0.044 | 0.036 | 0.044 | Antimetabolite | |||
| 0.099 | 0.091 | 0.62 | MAO inhibitor | 0.62 0.005 CHEMBL187265 0.585 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.06 | 0.056 | 0.147 | Transcription factor RelA inhibitor | 0.147 0.003 CHEMBL187265 0.124 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.03 | 0.027 | 0.137 | Catechol O-methyltransferase inhibitor | 0.137 0.004 CHEMBL187265 0.043 0.012 CHEMBL389166 | CHEMBL187265 | |
| 0.011 | 0.007 | 0.011 | Purinergic P2Y2 agonist | |||
| 0.018 | 0.015 | 0.02 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.02 0.013 CHEMBL389166 | CHEMBL389166 | |
| 0.014 | 0.011 | 0.014 | Adenosine A2b receptor agonist | |||
| 0.015 | 0.013 | 0.02 | Antibiotic Tetracycline-like | 0.02 0.004 CHEMBL187265 0.02 0.004 CHEMBL389166 | CHEMBL389166 | |
| 0.016 | 0.015 | 0.016 | Adenosine A3 receptor agonist | |||
| 0.063 | 0.063 | 0.08 | Protein kinase C beta inhibitor | 0.08 0.03 CHEMBL187265 0.079 0.032 CHEMBL389166 | CHEMBL187265 | |
| 0.025 | 0.026 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 CHEMBL389166 | CHEMBL389166 | |
| 0.11 | 0.115 | 0.131 | Vanilloid 1 agonist | 0.131 0.064 CHEMBL187265 0.13 0.066 CHEMBL389166 | CHEMBL187265 | |
| 0.046 | 0.054 | 0.096 | Leukotriene B4 antagonist | 0.096 0.011 CHEMBL187265 0.091 0.012 CHEMBL389166 | CHEMBL187265 | |
| 0.032 | 0.042 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.028 CHEMBL187265 | CHEMBL187265 | |
| 0.043 | 0.052 | 0.059 | Squalene epoxidase inhibitor | 0.059 0.021 CHEMBL187265 0.051 0.032 CHEMBL389166 | CHEMBL187265 | |
| 0.13 | 0.147 | 0.25 | Antimitotic | 0.25 0.06 CHEMBL187265 0.158 0.114 CHEMBL389166 | CHEMBL187265 | |
| 0.029 | 0.046 | 0.038 | Protein kinase C beta I inhibitor | 0.036 0.015 CHEMBL187265 0.038 0.012 CHEMBL389166 | CHEMBL389166 | |
| 0.044 | 0.064 | 0.052 | Heparanase inhibitor | 0.052 0.04 CHEMBL389166 | CHEMBL389166 | |
| 0.091 | 0.112 | 0.417 | Tubulin antagonist | 0.417 0.011 CHEMBL187265 0.299 0.019 CHEMBL389166 | CHEMBL187265 | |
| 0.04 | 0.063 | 0.056 | Argininosuccinate synthase inhibitor | 0.052 0.045 CHEMBL187265 0.056 0.04 CHEMBL389166 | CHEMBL389166 | |
| 0.048 | 0.076 | 0.095 | CDC25B inhibitor | 0.095 0.018 CHEMBL187265 0.083 0.025 CHEMBL389166 | CHEMBL187265 | |
| 0.048 | 0.077 | 0.12 | Leukotriene synthesis inhibitor | 0.118 0.017 CHEMBL187265 0.12 0.017 CHEMBL389166 | CHEMBL389166 | |
| 0.166 | 0.196 | 0.4 | Transcription factor STAT inhibitor | 0.4 0.019 CHEMBL187265 0.382 0.023 CHEMBL389166 | CHEMBL187265 | |
| 0.19 | 0.221 | 0.731 | GABA C receptor rho-3 antagonist | 0.731 0.003 CHEMBL187265 0.705 0.003 CHEMBL389166 | CHEMBL187265 | |
| 0.034 | 0.068 | 0.306 | Beta tubulin antagonist | 0.306 0.005 CHEMBL187265 0.235 0.006 CHEMBL389166 | CHEMBL187265 | |
| 0.072 | 0.109 | 0.082 | T cell inhibitor | 0.082 0.058 CHEMBL187265 0.081 0.063 CHEMBL389166 | CHEMBL187265 | |
| 0.059 | 0.096 | 0.27 | Keratolytic | 0.27 0.005 CHEMBL187265 0.22 0.007 CHEMBL389166 | CHEMBL187265 | |
| 0.057 | 0.096 | 0.149 | Ornithine decarboxylase inhibitor | 0.149 0.011 CHEMBL187265 0.145 0.012 CHEMBL389166 | CHEMBL187265 | |
| 0.026 | 0.069 | 0.052 | Retinoic acid alpha receptor agonist | 0.048 0.016 CHEMBL187265 0.052 0.013 CHEMBL389166 | CHEMBL389166 | |
| 0.192 | 0.234 | 0.344 | DNA directed DNA polymerase inhibitor | 0.344 0.14 CHEMBL187265 0.317 0.154 CHEMBL389166 | CHEMBL187265 | |
| 0.114 | 0.156 | 0.523 | Pyruvate kinase inhibitor | 0.523 0.007 CHEMBL187265 0.498 0.009 CHEMBL389166 | CHEMBL187265 | |
| 0.014 | 0.057 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.012 CHEMBL389166 | CHEMBL389166 | |
| 0.075 | 0.118 | 0.119 | Interleukin 12 antagonist | 0.119 0.03 CHEMBL187265 0.115 0.034 CHEMBL389166 | CHEMBL187265 | |
| 0.069 | 0.113 | 0.227 | D-Ala-D-Ala ligase inhibitor | 0.227 0.003 CHEMBL187265 0.201 0.003 CHEMBL389166 | CHEMBL187265 | |
| 0.012 | 0.057 | 0.032 | Leukotriene B4 receptor 2 antagonist | 0.032 0.008 CHEMBL187265 0.024 0.013 CHEMBL389166 | CHEMBL187265 | |
| 0.009 | 0.054 | 0.044 | Estrone sulfatase inhibitor | 0.044 0.008 CHEMBL187265 0.033 0.01 CHEMBL389166 | CHEMBL187265 | |
| 0.092 | 0.138 | 0.237 | Cyclooxygenase inhibitor | 0.237 0.029 CHEMBL187265 0.209 0.038 CHEMBL389166 | CHEMBL187265 | |
| 0.033 | 0.079 | 0.069 | Cholesterol esterase inhibitor | 0.069 0.011 CHEMBL187265 0.064 0.014 CHEMBL389166 | CHEMBL187265 | |
| 0.101 | 0.149 | 0.376 | Mcl-1 antagonist | 0.376 0.013 CHEMBL187265 0.314 0.021 CHEMBL389166 | CHEMBL187265 | |
| 0.013 | 0.061 | 0.021 | Prostaglandin F2 alpha agonist | 0.021 0.019 CHEMBL389166 | CHEMBL389166 | |
| 0.031 | 0.08 | 0.074 | DNA gyrase subunit A inhibitor | 0.074 0.006 CHEMBL187265 0.071 0.006 CHEMBL389166 | CHEMBL187265 | |
| 0.02 | 0.074 | 0.076 | Carbonic anhydrase XII inhibitor | 0.076 0.027 CHEMBL187265 0.062 0.032 CHEMBL389166 | CHEMBL187265 | |
| 0.081 | 0.136 | 0.194 | Cyclooxygenase 2 inhibitor | 0.194 0.033 CHEMBL187265 0.171 0.041 CHEMBL389166 | CHEMBL187265 | |
| 0.009 | 0.066 | 0.134 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.134 0.003 CHEMBL187265 0.106 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.037 | 0.107 | 0.103 | Leukotriene antagonist | 0.103 0.02 CHEMBL187265 0.101 0.021 CHEMBL389166 | CHEMBL187265 | |
| 0.033 | 0.105 | 0.046 | Cytokine production stimulant | 0.046 0.042 CHEMBL389166 | CHEMBL389166 | |
| 0.015 | 0.091 | 0.053 | Cathepsin L2 inhibitor | 0.053 0.021 CHEMBL187265 0.041 0.028 CHEMBL389166 | CHEMBL187265 | |
| 0.009 | 0.086 | 0.039 | Leukotriene B4 receptor 1 antagonist | 0.039 0.012 CHEMBL187265 0.028 0.019 CHEMBL389166 | CHEMBL187265 | |
| 0.016 | 0.097 | 0.25 | Estradiol 17 beta-dehydrogenase inhibitor | 0.25 0.004 CHEMBL187265 0.199 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.047 | 0.13 | 0.322 | Macrophage migration inhibitory factor inhibitor | 0.322 0.004 CHEMBL187265 0.259 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.026 | 0.11 | 0.094 | Maillard reaction inhibitor | 0.094 0.019 CHEMBL187265 0.071 0.028 CHEMBL389166 | CHEMBL187265 | |
| 0.037 | 0.12 | 0.074 | Sphingosine kinase inhibitor | 0.074 0.021 CHEMBL187265 0.062 0.035 CHEMBL389166 | CHEMBL187265 | |
| 0.011 | 0.096 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.022 0.011 CHEMBL187265 0.021 0.016 CHEMBL389166 | CHEMBL187265 | |
| 0.037 | 0.123 | 0.252 | Cyclin B3 inhibitor | 0.252 0.004 CHEMBL187265 0.192 0.007 CHEMBL389166 | CHEMBL187265 | |
| 0.036 | 0.126 | 0.061 | Transcription factor AP-1 inhibitor | 0.061 0.043 CHEMBL187265 | CHEMBL187265 | |
| 0.03 | 0.128 | 0.09 | Dopamine agonist | 0.09 0.031 CHEMBL187265 | CHEMBL187265 | |
| 0.01 | 0.111 | 0.13 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.13 0.004 CHEMBL187265 0.121 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.029 | 0.132 | 0.087 | Androgen agonist | 0.076 0.026 CHEMBL187265 0.087 0.02 CHEMBL389166 | CHEMBL389166 | |
| 0.057 | 0.167 | 0.121 | mTOR complex 2 inhibitor | 0.109 0.025 CHEMBL187265 0.121 0.017 CHEMBL389166 | CHEMBL389166 | |
| 0.04 | 0.153 | 0.064 | Leukotriene C antagonist | 0.062 0.024 CHEMBL187265 0.064 0.022 CHEMBL389166 | CHEMBL389166 | |
| 0.032 | 0.147 | 0.127 | CD45 antagonist | 0.127 0.007 CHEMBL187265 0.11 0.008 CHEMBL389166 | CHEMBL187265 | |
| 0.023 | 0.139 | 0.143 | Protease activated receptor antagonist | 0.143 0.005 CHEMBL187265 0.082 0.022 CHEMBL389166 | CHEMBL187265 | |
| 0.04 | 0.157 | 0.107 | GABA aminotransferase inhibitor | 0.09 0.035 CHEMBL187265 0.107 0.022 CHEMBL389166 | CHEMBL389166 | |
| 0.021 | 0.138 | 0.042 | Glutamate (mGluR8) agonist | 0.041 0.02 CHEMBL187265 0.042 0.019 CHEMBL389166 | CHEMBL389166 | |
| 0.045 | 0.164 | 0.188 | Urease inhibitor | 0.188 0.012 CHEMBL187265 0.152 0.022 CHEMBL389166 | CHEMBL187265 | |
| 0.032 | 0.153 | 0.471 | MAO B inhibitor | 0.471 0.005 CHEMBL187265 0.447 0.006 CHEMBL389166 | CHEMBL187265 | |
| 0.102 | 0.223 | 0.145 | Lipocortins synthesis antagonist | 0.136 0.128 CHEMBL187265 0.145 0.113 CHEMBL389166 | CHEMBL389166 | |
| 0.022 | 0.144 | 0.19 | Alcohol oxidase inhibitor | 0.139 0.011 CHEMBL187265 0.19 0.007 CHEMBL389166 | CHEMBL389166 | |
| 0.086 | 0.21 | 0.174 | Anesthetic general | 0.14 0.125 CHEMBL187265 0.174 0.091 CHEMBL389166 | CHEMBL389166 | |
| 0.017 | 0.142 | 0.084 | DNA-dependent protein kinase inhibitor | 0.084 0.008 CHEMBL187265 0.069 0.011 CHEMBL389166 | CHEMBL187265 | |
| 0.088 | 0.216 | 0.337 | Interleukin antagonist | 0.337 0.041 CHEMBL187265 0.28 0.052 CHEMBL389166 | CHEMBL187265 | |
| 0.053 | 0.182 | 0.113 | MAP kinase kinase 7 inhibitor | 0.102 0.011 CHEMBL187265 0.113 0.005 CHEMBL389166 | CHEMBL389166 | |
| 0.025 | 0.155 | 0.041 | Leukotriene C4 antagonist | 0.039 0.027 CHEMBL187265 0.041 0.022 CHEMBL389166 | CHEMBL389166 | |
| 0.043 | 0.175 | 0.082 | Glutamate (mGluR6) antagonist | 0.072 0.036 CHEMBL187265 0.082 0.022 CHEMBL389166 | CHEMBL389166 | |
| 0.014 | 0.147 | 0.162 | Dopamine D5 agonist | 0.126 0.003 CHEMBL187265 0.162 0.003 CHEMBL389166 | CHEMBL389166 | |
| 0.179 | 0.314 | 0.404 | Calcium channel L-type activator | 0.309 0.15 CHEMBL187265 0.404 0.079 CHEMBL389166 | CHEMBL389166 | |
| 0.024 | 0.16 | 0.147 | GABA B receptor antagonist | 0.147 0.004 CHEMBL187265 0.125 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.011 | 0.15 | 0.047 | Dopamine D2 agonist | 0.047 0.029 CHEMBL187265 | CHEMBL187265 | |
| 0.101 | 0.241 | 0.203 | MAP kinase kinase 4 inhibitor | 0.172 0.031 CHEMBL187265 0.203 0.013 CHEMBL389166 | CHEMBL389166 | |
| 0.086 | 0.227 | 0.44 | GABA C receptor rho-2 antagonist | 0.44 0.003 CHEMBL187265 0.382 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.024 | 0.166 | 0.087 | Purinergic P2X4 antagonist | 0.069 0.01 CHEMBL187265 0.087 0.005 CHEMBL389166 | CHEMBL389166 | |
| 0.128 | 0.273 | 0.272 | Angiogenesis inhibitor | 0.272 0.108 CHEMBL187265 | CHEMBL187265 | |
| 0.011 | 0.157 | 0.033 | Thyroid hormone agonist | 0.031 0.011 CHEMBL187265 0.033 0.01 CHEMBL389166 | CHEMBL389166 | |
| 0.12 | 0.274 | 0.247 | Gastrin inhibitor | 0.21 0.134 CHEMBL187265 0.247 0.083 CHEMBL389166 | CHEMBL389166 | |
| 0.012 | 0.172 | 0.057 | Carbonic anhydrase inhibitor | 0.057 0.048 CHEMBL187265 | CHEMBL187265 | |
| 0.038 | 0.212 | 0.067 | Glycine receptor agonist | 0.067 0.062 CHEMBL187265 | CHEMBL187265 | |
| 0.031 | 0.206 | 0.121 | Aryl hydrocarbon receptor antagonist | 0.119 0.008 CHEMBL187265 0.121 0.008 CHEMBL389166 | CHEMBL389166 | |
| 0.064 | 0.239 | 0.392 | Cholinergic | 0.392 0.01 CHEMBL187265 0.288 0.02 CHEMBL389166 | CHEMBL187265 | |
| 0.006 | 0.183 | 0.043 | Carbonic anhydrase IV inhibitor | 0.043 0.03 CHEMBL187265 | CHEMBL187265 | |
| 0.038 | 0.221 | 0.072 | Heme oxygenase stimulant | 0.066 0.031 CHEMBL187265 0.072 0.022 CHEMBL389166 | CHEMBL389166 | |
| 0.043 | 0.226 | 0.099 | Glutathione S-transferase inhibitor | 0.099 0.038 CHEMBL187265 0.09 0.048 CHEMBL389166 | CHEMBL187265 | |
| 0.06 | 0.246 | 0.672 | Aryl hydrocarbon receptor agonist | 0.672 0.01 CHEMBL187265 0.637 0.012 CHEMBL389166 | CHEMBL187265 | |
| 0.021 | 0.207 | 0.111 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.081 0.016 CHEMBL187265 0.111 0.008 CHEMBL389166 | CHEMBL389166 | |
| 0.027 | 0.214 | 0.182 | Androgen antagonist | 0.182 0.016 CHEMBL187265 0.18 0.016 CHEMBL389166 | CHEMBL187265 | |
| 0.031 | 0.221 | 0.305 | Butyrylcholinesterase inhibitor | 0.305 0.01 CHEMBL187265 0.23 0.017 CHEMBL389166 | CHEMBL187265 | |
| 0.03 | 0.224 | 0.125 | Glutamate (mGluR7) antagonist | 0.105 0.008 CHEMBL187265 0.125 0.004 CHEMBL389166 | CHEMBL389166 | |
| 0.044 | 0.238 | 0.293 | GABA C receptor antagonist | 0.293 0.005 CHEMBL187265 0.243 0.007 CHEMBL389166 | CHEMBL187265 | |
| 0.015 | 0.213 | 0.036 | Glutamate (mGluR3) agonist | 0.036 0.015 CHEMBL389166 | CHEMBL389166 | |
| 0.032 | 0.231 | 0.204 | Myeloperoxidase inhibitor | 0.204 0.005 CHEMBL187265 0.156 0.01 CHEMBL389166 | CHEMBL187265 | |
| 0.011 | 0.213 | 0.084 | Potassium channel Kv1.3 blocker | 0.051 0.028 CHEMBL187265 0.084 0.011 CHEMBL389166 | CHEMBL389166 | |
| 0.023 | 0.225 | 0.159 | Glutamate decarboxylase inhibitor | 0.159 0.012 CHEMBL187265 0.128 0.018 CHEMBL389166 | CHEMBL187265 | |
| 0.135 | 0.337 | 0.263 | Calcium channel activator | 0.214 0.192 CHEMBL187265 0.263 0.132 CHEMBL389166 | CHEMBL389166 | |
| 0.043 | 0.25 | 0.285 | GABA C receptor rho-1 antagonist | 0.285 0.004 CHEMBL187265 0.245 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.027 | 0.234 | 0.054 | Vanilloid 2 antagonist | 0.054 0.033 CHEMBL187265 | CHEMBL187265 | |
| 0.033 | 0.244 | 0.089 | Ryanodine receptor antagonist | 0.071 0.016 CHEMBL187265 0.089 0.005 CHEMBL389166 | CHEMBL389166 | |
| 0.008 | 0.221 | 0.043 | Retinoid X alpha receptor agonist | 0.034 0.026 CHEMBL187265 0.043 0.018 CHEMBL389166 | CHEMBL389166 | |
| 0.096 | 0.309 | 0.606 | Superoxide dismutase inhibitor | 0.606 0.006 CHEMBL187265 0.511 0.012 CHEMBL389166 | CHEMBL187265 | |
| 0.044 | 0.259 | 0.139 | Proteasome inhibitor | 0.139 0.053 CHEMBL187265 0.12 0.065 CHEMBL389166 | CHEMBL187265 | |
| 0.037 | 0.252 | 0.157 | HIV-1 integrase (Overall Integration) inhibitor | 0.157 0.023 CHEMBL187265 0.14 0.029 CHEMBL389166 | CHEMBL187265 | |
| 0.059 | 0.277 | 0.165 | Diuretic | 0.165 0.065 CHEMBL187265 0.153 0.075 CHEMBL389166 | CHEMBL187265 | |
| 0.047 | 0.267 | 0.248 | Psychostimulant | 0.21 0.074 CHEMBL187265 0.248 0.059 CHEMBL389166 | CHEMBL389166 | |
| 0.117 | 0.34 | 0.268 | Sodium/bile acid cotransporter inhibitor | 0.244 0.134 CHEMBL187265 0.268 0.11 CHEMBL389166 | CHEMBL389166 | |
| 0.045 | 0.273 | 0.106 | Granulocyte macrophage colony stimulating factor agonist | 0.102 0.032 CHEMBL187265 0.106 0.028 CHEMBL389166 | CHEMBL389166 | |
| 0.019 | 0.248 | 0.056 | Vanilloid 3 antagonist | 0.038 0.028 CHEMBL187265 0.056 0.005 CHEMBL389166 | CHEMBL389166 | |
| 0.033 | 0.27 | 0.101 | Bronchodilator | 0.089 0.076 CHEMBL187265 0.101 0.063 CHEMBL389166 | CHEMBL389166 | |
| 0.018 | 0.256 | 0.102 | Phenylalanine 4-hydroxylase inhibitor | 0.095 0.028 CHEMBL187265 0.102 0.025 CHEMBL389166 | CHEMBL389166 | |
| 0.045 | 0.286 | 0.094 | ABCA1 expression enhancer | 0.094 0.058 CHEMBL187265 0.09 0.066 CHEMBL389166 | CHEMBL187265 | |
| 0.033 | 0.283 | 0.18 | Prolactin inhibitor | 0.18 0.013 CHEMBL187265 0.153 0.021 CHEMBL389166 | CHEMBL187265 | |
| 0.009 | 0.263 | 0.039 | Estrogen-related receptor alpha antagonist | 0.039 0.018 CHEMBL187265 0.032 0.023 CHEMBL389166 | CHEMBL187265 | |
| 0.02 | 0.274 | 0.132 | CYP2A6 inhibitor | 0.092 0.04 CHEMBL187265 0.132 0.022 CHEMBL389166 | CHEMBL389166 | |
| 0.014 | 0.268 | 0.093 | Protein kinase (CK2) beta inhibitor | 0.093 0.004 CHEMBL187265 0.082 0.004 CHEMBL389166 | CHEMBL187265 | |
| 0.05 | 0.305 | 0.185 | TRPA1 agonist | 0.164 0.023 CHEMBL187265 0.185 0.014 CHEMBL389166 | CHEMBL389166 | |
| 0.091 | 0.346 | 0.308 | Transcription factor STAT3 inhibitor | 0.308 0.049 CHEMBL187265 0.289 0.059 CHEMBL389166 | CHEMBL187265 | |
| 0.005 | 0.265 | 0.039 | Retinoid X receptor agonist | 0.039 0.023 CHEMBL389166 | CHEMBL389166 | |
| 0.017 | 0.279 | 0.139 | Porphobilinogen synthase inhibitor | 0.104 0.034 CHEMBL187265 0.139 0.023 CHEMBL389166 | CHEMBL389166 | |
| 0.047 | 0.323 | 0.116 | Estrogen-related receptor beta agonist | 0.099 0.026 CHEMBL187265 0.116 0.012 CHEMBL389166 | CHEMBL389166 | |
| 0.012 | 0.29 | 0.124 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.124 0.011 CHEMBL187265 0.096 0.016 CHEMBL389166 | CHEMBL187265 | |
| 0.017 | 0.298 | 0.083 | Dopamine D1 antagonist | 0.083 0.031 CHEMBL187265 0.08 0.033 CHEMBL389166 | CHEMBL187265 | |
| 0.049 | 0.333 | 0.371 | Heat shock protein 90 antagonist | 0.371 0.005 CHEMBL187265 0.319 0.008 CHEMBL389166 | CHEMBL187265 | |
| 0.045 | 0.329 | 0.166 | Phospholipase A2 inhibitor | 0.166 0.062 CHEMBL187265 0.161 0.065 CHEMBL389166 | CHEMBL187265 | |
| 0.021 | 0.314 | 0.158 | Heat shock protein 90 beta antagonist | 0.158 0.004 CHEMBL187265 0.134 0.005 CHEMBL389166 | CHEMBL187265 | |
| 0.017 | 0.311 | 0.239 | Protein kinase (CK2) inhibitor | 0.239 0.013 CHEMBL187265 0.199 0.019 CHEMBL389166 | CHEMBL187265 | |
| 0.015 | 0.31 | 0.058 | Aconitate hydratase inhibitor | 0.051 0.036 CHEMBL187265 0.058 0.028 CHEMBL389166 | CHEMBL389166 | |
| 0.016 | 0.319 | 0.05 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.05 0.014 CHEMBL187265 0.046 0.019 CHEMBL389166 | CHEMBL187265 | |
| 0.004 | 0.309 | 0.046 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.046 0.013 CHEMBL187265 0.04 0.015 CHEMBL389166 | CHEMBL187265 | |
| 0.02 | 0.326 | 0.087 | Cathepsin G inhibitor | 0.086 0.04 CHEMBL187265 0.087 0.039 CHEMBL389166 | CHEMBL389166 | |
| 0.107 | 0.417 | 0.364 | Tyrosine 3 hydroxylase inhibitor | 0.35 0.016 CHEMBL187265 0.364 0.013 CHEMBL389166 | CHEMBL389166 | |
| 0.016 | 0.327 | 0.312 | Protein kinase (CK2) alpha inhibitor | 0.312 0.01 CHEMBL187265 0.233 0.018 CHEMBL389166 | CHEMBL187265 | |
| 0.048 | 0.361 | 0.26 | Amyloid beta precursor protein antagonist | 0.26 0.029 CHEMBL187265 0.244 0.035 CHEMBL389166 | CHEMBL187265 | |
| 0.029 | 0.35 | 0.085 | Alpha 2c adrenoreceptor antagonist | 0.085 0.081 CHEMBL389166 | CHEMBL389166 | |
| 0.032 | 0.355 | 0.098 | Bile acid receptor antagonist | 0.098 0.053 CHEMBL187265 0.093 0.067 CHEMBL389166 | CHEMBL187265 | |
| 0.045 | 0.369 | 0.181 | Farnesoid X receptor antagonist | 0.181 0.029 CHEMBL187265 0.146 0.057 CHEMBL389166 | CHEMBL187265 | |
| 0.005 | 0.329 | 0.044 | Dopamine D5 antagonist | 0.044 0.029 CHEMBL187265 | CHEMBL187265 | |
| 0.016 | 0.344 | 0.079 | Cyclin D1 inhibitor | 0.079 0.019 CHEMBL187265 0.078 0.02 CHEMBL389166 | CHEMBL187265 | |
| 0.027 | 0.356 | 0.166 | GABA C receptor agonist | 0.166 0.029 CHEMBL187265 0.166 0.029 CHEMBL389166 | CHEMBL389166 | |
| 0.022 | 0.353 | 0.041 | Heme oxygenase inhibitor | 0.041 0.039 CHEMBL187265 0.041 0.039 CHEMBL389166 | CHEMBL389166 | |
| 0.009 | 0.347 | 0.096 | Cyclin B2 inhibitor | 0.096 0.009 CHEMBL187265 0.072 0.02 CHEMBL389166 | CHEMBL187265 | |
| 0.032 | 0.37 | 0.39 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.39 0.027 CHEMBL187265 0.338 0.038 CHEMBL389166 | CHEMBL187265 | |
| 0.012 | 0.353 | 0.04 | Retinoid X receptor antagonist | 0.038 0.026 CHEMBL187265 0.04 0.024 CHEMBL389166 | CHEMBL389166 | |
| 0.076 | 0.425 | 0.288 | MAP-kinase-activated kinase 5 inhibitor | 0.288 0.037 CHEMBL187265 0.241 0.065 CHEMBL389166 | CHEMBL187265 | |
| 0.013 | 0.37 | 0.051 | mTOR inhibitor | 0.051 0.037 CHEMBL187265 | CHEMBL187265 | |
| 0.023 | 0.394 | 0.103 | Aminopeptidase B inhibitor | 0.103 0.063 CHEMBL389166 | CHEMBL389166 | |
| 0.01 | 0.381 | 0.099 | Cyclin B1 inhibitor | 0.099 0.011 CHEMBL187265 0.077 0.025 CHEMBL389166 | CHEMBL187265 | |
| 0.022 | 0.395 | 0.071 | Beta 3 adrenoreceptor antagonist | 0.071 0.032 CHEMBL187265 0.071 0.032 CHEMBL389166 | CHEMBL389166 | |
| 0.017 | 0.396 | 0.064 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.045 CHEMBL187265 0.064 0.045 CHEMBL389166 | CHEMBL389166 | |
| 0.016 | 0.395 | 0.068 | Beta adrenoreceptor antagonist | 0.068 0.042 CHEMBL187265 0.066 0.044 CHEMBL389166 | CHEMBL187265 | |
| 0.015 | 0.396 | 0.067 | Aminopeptidase I inhibitor | 0.067 0.058 CHEMBL389166 | CHEMBL389166 | |
| 0.002 | 0.393 | 0.032 | Dopamine autoreceptor agonist | 0.032 0.012 CHEMBL389166 | CHEMBL389166 | |
| 0.008 | 0.4 | 0.045 | Liver X receptor alpha agonist | 0.038 0.033 CHEMBL187265 0.045 0.024 CHEMBL389166 | CHEMBL389166 | |
| 0.01 | 0.409 | 0.069 | Phosphodiesterase V inhibitor | 0.069 0.053 CHEMBL389166 | CHEMBL389166 | |
| 0.024 | 0.429 | 0.336 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.336 0.012 CHEMBL187265 0.249 0.029 CHEMBL389166 | CHEMBL187265 | |
| 0.066 | 0.472 | 0.222 | Death-associated protein kinase 2 inhibitor | 0.222 0.022 CHEMBL187265 0.187 0.046 CHEMBL389166 | CHEMBL187265 | |
| 0.016 | 0.424 | 0.061 | Elastase 1 inhibitor | 0.061 0.06 CHEMBL187265 | CHEMBL187265 | |
| 0.005 | 0.416 | 0.082 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.082 0.021 CHEMBL187265 0.051 0.036 CHEMBL389166 | CHEMBL187265 | |
| 0.022 | 0.434 | 0.351 | Dyrk kinase inhibitor | 0.351 0.037 CHEMBL187265 0.31 0.049 CHEMBL389166 | CHEMBL187265 | |
| 0.049 | 0.463 | 0.224 | Tumour necrosis factor antagonist | 0.224 0.04 CHEMBL187265 0.205 0.05 CHEMBL389166 | CHEMBL187265 | |
| 0.007 | 0.426 | 0.08 | NMDA receptor glycine site agonist | 0.08 0.029 CHEMBL389166 | CHEMBL389166 | |
| 0.011 | 0.431 | 0.071 | Adenylate cyclase 1 inhibitor | 0.044 0.035 CHEMBL187265 0.071 0.012 CHEMBL389166 | CHEMBL389166 | |
| 0.015 | 0.444 | 0.054 | Pregnane X receptor antagonist | 0.054 0.048 CHEMBL389166 | CHEMBL389166 | |
| 0.007 | 0.439 | 0.083 | Cyclin B inhibitor | 0.083 0.014 CHEMBL187265 0.063 0.028 CHEMBL389166 | CHEMBL187265 | |
| 0.011 | 0.446 | 0.049 | Beta 2 adrenoreceptor antagonist | 0.048 0.039 CHEMBL187265 0.049 0.038 CHEMBL389166 | CHEMBL389166 | |
| 0.008 | 0.453 | 0.03 | Estrogen-related receptor gamma antagonist | 0.03 0.015 CHEMBL389166 | CHEMBL389166 | |
| 0.014 | 0.466 | 0.072 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.07 0.028 CHEMBL187265 0.072 0.026 CHEMBL389166 | CHEMBL389166 | |
| 0.006 | 0.46 | 0.046 | Delayed rectifier potassium channel blocker | 0.046 0.014 CHEMBL389166 | CHEMBL389166 | |
| 0.012 | 0.47 | 0.063 | NMDA receptor agonist | 0.063 0.043 CHEMBL389166 | CHEMBL389166 | |
| 0.016 | 0.476 | 0.061 | Dihydroorotate oxidase inhibitor | 0.061 0.027 CHEMBL187265 0.056 0.036 CHEMBL389166 | CHEMBL187265 | |
| 0.014 | 0.474 | 0.069 | Sirtuin 1 inhibitor | 0.069 0.045 CHEMBL389166 | CHEMBL389166 | |
| 0.03 | 0.49 | 0.17 | Cytokine production inhibitor | 0.168 0.05 CHEMBL187265 0.17 0.049 CHEMBL389166 | CHEMBL389166 | |
| 0.037 | 0.504 | 0.341 | DNA polymerase beta inhibitor | 0.341 0.143 CHEMBL187265 0.324 0.152 CHEMBL389166 | CHEMBL187265 | |
| 0.027 | 0.5 | 0.382 | Heat shock protein 90 alpha antagonist | 0.382 0.006 CHEMBL187265 0.335 0.01 CHEMBL389166 | CHEMBL187265 | |
| 0.006 | 0.5 | 0.053 | Cyclin-dependent kinase 6 inhibitor | 0.053 0.05 CHEMBL187265 | CHEMBL187265 | |
| 0.023 | 0.522 | 0.435 | Prostaglandin dehydrogenase inhibitor | 0.435 0.057 CHEMBL187265 0.418 0.062 CHEMBL389166 | CHEMBL187265 | |
| 0.012 | 0.516 | 0.045 | Aldosterone antagonist | 0.045 0.037 CHEMBL389166 | CHEMBL389166 | |
| 0.028 | 0.534 | 0.14 | Interleukin 1 antagonist | 0.14 0.065 CHEMBL187265 | CHEMBL187265 | |
| 0.004 | 0.512 | 0.039 | NMDA receptor subunit 3B antagonist | 0.039 0.036 CHEMBL389166 | CHEMBL389166 | |
| 0.019 | 0.536 | 0.275 | I kappa B kinase epsilon inhibitor | 0.266 0.029 CHEMBL187265 0.275 0.025 CHEMBL389166 | CHEMBL389166 | |
| 0.005 | 0.527 | 0.112 | Phosphodiesterase 4D inhibitor | 0.112 0.032 CHEMBL187265 0.1 0.037 CHEMBL389166 | CHEMBL187265 | |
| 0.002 | 0.525 | 0.033 | Glutamate (mGluR1a) agonist | 0.023 0.014 CHEMBL187265 0.033 0.008 CHEMBL389166 | CHEMBL389166 | |
| 0.016 | 0.542 | 0.106 | Caspase 3 inhibitor | 0.106 0.082 CHEMBL389166 | CHEMBL389166 | |
| 0.008 | 0.537 | 0.052 | Phosphatidylinositol kinase inhibitor | 0.052 0.051 CHEMBL187265 | CHEMBL187265 | |
| 0.015 | 0.556 | 0.06 | CXC chemokine 1 receptor antagonist | 0.056 0.027 CHEMBL187265 0.06 0.022 CHEMBL389166 | CHEMBL389166 | |
| 0.007 | 0.551 | 0.088 | Inducible nitric-oxide synthase inhibitor | 0.088 0.05 CHEMBL187265 0.076 0.069 CHEMBL389166 | CHEMBL187265 | |
| 0.031 | 0.576 | 0.253 | Thyroid hormone antagonist | 0.216 0.148 CHEMBL187265 0.253 0.121 CHEMBL389166 | CHEMBL389166 | |
| 0.032 | 0.578 | 0.236 | Thyroid hormone beta antagonist | 0.197 0.157 CHEMBL187265 0.236 0.127 CHEMBL389166 | CHEMBL389166 | |
| 0.003 | 0.553 | 0.048 | Fructose-1,6-bisphosphatase inhibitor | 0.048 0.026 CHEMBL389166 | CHEMBL389166 | |
| 0.017 | 0.578 | 0.376 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.376 0.044 CHEMBL187265 0.347 0.051 CHEMBL389166 | CHEMBL187265 | |
| 0.002 | 0.567 | 0.033 | Sirtuin 2 inhibitor | 0.033 0.023 CHEMBL389166 | CHEMBL389166 | |
| 0.013 | 0.587 | 0.088 | Ferrochelatase inhibitor | 0.088 0.085 CHEMBL389166 | CHEMBL389166 | |
| 0.014 | 0.594 | 0.081 | GABA B receptor agonist | 0.079 0.044 CHEMBL187265 0.081 0.04 CHEMBL389166 | CHEMBL389166 | |
| 0.019 | 0.605 | 0.114 | Acetylcholine release stimulant | 0.114 0.058 CHEMBL389166 | CHEMBL389166 | |
| 0.045 | 0.634 | 0.32 | Insulysin inhibitor | 0.32 0.047 CHEMBL187265 0.31 0.052 CHEMBL389166 | CHEMBL187265 | |
| 0.029 | 0.628 | 0.176 | Histone acetyltransferase inhibitor | 0.161 0.125 CHEMBL187265 0.176 0.106 CHEMBL389166 | CHEMBL389166 | |
| 0.012 | 0.613 | 0.271 | MAP kinase kinase 2 inhibitor | 0.271 0.045 CHEMBL187265 0.243 0.057 CHEMBL389166 | CHEMBL187265 | |
| 0.004 | 0.612 | 0.053 | GABA receptor antagonist | 0.053 0.039 CHEMBL389166 | CHEMBL389166 | |
| 0.019 | 0.628 | 0.14 | Sphingosine 1-phosphate receptor 4 antagonist | 0.14 0.043 CHEMBL389166 | CHEMBL389166 | |
| 0.019 | 0.628 | 0.394 | Streptokinase A inhibitor | 0.377 0.054 CHEMBL187265 0.394 0.048 CHEMBL389166 | CHEMBL389166 | |
| 0.009 | 0.618 | 0.087 | MAP kinase kinase 1 inhibitor | 0.087 0.075 CHEMBL187265 | CHEMBL187265 | |
| 0.008 | 0.627 | 0.045 | Dopamine beta hydroxylase inhibitor | 0.045 0.043 CHEMBL389166 | CHEMBL389166 | |
| 0.004 | 0.635 | 0.078 | NMDA receptor antagonist | 0.075 0.073 CHEMBL187265 0.078 0.069 CHEMBL389166 | CHEMBL389166 | |
| 0.005 | 0.648 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.019 CHEMBL389166 | CHEMBL389166 | |
| 0.015 | 0.661 | 0.126 | Interleukin 8 antagonist | 0.126 0.054 CHEMBL187265 0.123 0.058 CHEMBL389166 | CHEMBL187265 | |
| 0.022 | 0.671 | 0.127 | MAP3K9 inhibitor | 0.127 0.1 CHEMBL389166 | CHEMBL389166 | |
| 0.005 | 0.662 | 0.111 | Glycogen synthase kinase-3 alpha inhibitor | 0.11 0.094 CHEMBL187265 0.111 0.092 CHEMBL389166 | CHEMBL389166 | |
| 0.018 | 0.685 | 0.128 | Antipruritic | 0.128 0.126 CHEMBL389166 | CHEMBL389166 | |
| 0.072 | 0.752 | 0.208 | 5 Hydroxytryptamine 3E antagonist | 0.169 0.141 CHEMBL187265 0.208 0.05 CHEMBL389166 | CHEMBL389166 | |
| 0.057 | 0.745 | 0.248 | MAP kinase kinase 6 inhibitor | 0.248 0.193 CHEMBL389166 | CHEMBL389166 | |
| 0.02 | 0.741 | 0.156 | 3C-like protease (Human coronavirus) inhibitor | 0.156 0.091 CHEMBL389166 | CHEMBL389166 | |
| 0.01 | 0.736 | 0.088 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.088 0.052 CHEMBL389166 | CHEMBL389166 | |
| 0.011 | 0.757 | 0.275 | 5 Hydroxytryptamine 1E antagonist | 0.232 0.095 CHEMBL187265 0.275 0.049 CHEMBL389166 | CHEMBL389166 | |
| 0.018 | 0.773 | 0.222 | Transcription factor inhibitor | 0.222 0.208 CHEMBL389166 | CHEMBL389166 | |
| 0.007 | 0.773 | 0.154 | 5 Hydroxytryptamine 3A agonist | 0.095 0.082 CHEMBL187265 0.154 0.033 CHEMBL389166 | CHEMBL389166 | |
| 0.024 | 0.831 | 0.084 | CC chemokine 5 receptor agonist | 0.084 0.052 CHEMBL389166 | CHEMBL389166 | |
| 0.004 | 0.824 | 0.116 | Sphingosine 1-phosphate receptor 2 antagonist | 0.116 0.108 CHEMBL187265 0.116 0.108 CHEMBL389166 | CHEMBL389166 | |
| 0.002 | 0.825 | 0.061 | TRPA1 antagonist | 0.061 0.042 CHEMBL389166 | CHEMBL389166 | |
| 0.021 | 0.845 | 0.078 | Ca(v)3.1 blocker | 0.078 0.068 CHEMBL389166 | CHEMBL389166 | |
| 0.006 | 0.858 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | 0.123 0.116 CHEMBL389166 | CHEMBL389166 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |